We analyze the effect of Business Model Innovation (BMI) on the product innovation performance of firms, based on a dynamic capabilities theoretical framework. Our empirical study is based on a large-scale representative sample of cross-industry Swedish firms participating in the last three waves of the Community Innovation Survey (CIS) from 2006-2012. Our findings provide support for the dynamics capabilities theoretical framework as well as broad evidence of a significant and positive association between BMI and product innovation performance. Our results imply that BMI in the form of product innovations combined with different complementary innovations will act as isolating mechanisms towards replication by competitors. Therefore, managers should frame product innovations as part of a business model innovation and dynamically adapt the key elements of the firm's business model. 
Introduction
Business model innovation (BMI) have received considerable attention in management research (e.g., Casadesus-Masanell and Zhu, 2013; Demil, et al., 2015; Spieth, Schneckenberg, and Ricart, 2014) , but few empirical studies have addressed the issue of BMI and firm performance (Foss and Saebi, 2017; Lambert and Davidson, 2013; Schneider and Spieth, 2013) .
The research-based evidence for the positive effects of BMI on firm performance is primarily based on case studies (e.g., Brea-Solís, Casadesus-Masanell, and Grifell-Tatjé, 2015; Sosna, Trevinyo-Rodriguez, and Velamuri, 2010 ) and a few large scale empirical studies (e.g. Aspara et al, 2010; Cucculelli and Bettinelli, 2015) . Overall there is a dearth of studies derived from a broader evidence-based (Demil et al., 2015; Foss and Saebi, 2017; Lambert and Davidson, 2013; Schneider and Spieth, 2013; Spieth, Schneckenberg and Matzler, 2016) .
We define a focal firm's business model (BM) as the "design or architecture of the value creation, delivery, and capture mechanisms" (Teece 2010: 172) . In line with this definition, we define BMI as "designed, novel, and nontrivial changes to the key elements of a firm's BM and/or the architecture linking these elements" (Foss and Saebi, 2017:216) . Using a dynamic capabilities framework (Teece, 2007; , we expect that firms having the capacity to both introduce product innovations and organize and re-structure complementary and co-specialized assets, both internally and externally, as well as integrating and implementing these assets into a functioning BM, will outperform firms with less such capacity. At the same time, success is not self-evident, BMI can be a difficult and risky process (e.g., Sosna et al., 2010; Chesbrough, 2010) , requiring for instance, risky boundary-spanning activities (Zott and Amit, 2010) and implementation skills (Brea-Solis et al., 2015) . It may also be negatively impacted by technological uncertainties and liabilities of newness (Gerasymenko, De Clercq, and Sapienza, 2015) .
In this paper, we aim to contribute to the body of knowledge on BMI and innovation performance. Specifically, we aim to investigate whether firms engaging in BMI will exhibit superior product innovation performance, compared to firms only engaging in product innovation. Our empirical investigation is theoretically guided by the dynamic capabilities framework (Teece, 2006; .
A better understanding of the relation between BMI and firm performance is important for three reasons. Firstly, previous research on BMI and firm performance is primarily based on some case-studies of mostly successful business model innovators, such as Walmart (BreaSolis et al, 2015) , hence there is often a positive bias towards BMI in the research literature because of the biased selection of studied cases. A broader based empirical inquiry will give a more systematic view of the relationship between BMI and firm performance. Second, much of earlier BMI research has been mainly conceptual and descriptive rather than theoretical and explanatory (Foss and Saebi, 2017) . By grounding our investigation in the dynamic capabilities view of the firm (Teece, 2006; , we aim to provide a more solid base for cumulative BMI research. Third, there are also important implications for strategic and innovation management theory of a strong or weak relationship between BMI and firm performance, such as the relative emphasis on configurations and system models compared to more atomistic models of the firm and how competitive advantage is achieved (Demil et al, 2015; Kim and Min, 2015; Kulins, Leonardy and Weber, 2016; Spieth et al, 2016) .
Our findings highlight the superior product innovation performance of BMI-firms compared to firms only introducing product innovations. BMI-firms that simultaneously introduced product, and complementary innovations in processes, marketing and the organization were associated, significantly and positively, with the highest innovation performance, 28 % higher innovation performance than product innovators only in the full model (R 2 = 0.375). Overall the findings based on one of the few large-scale data study of BMI and innovation performance support the view that is BMI superior to product innovation only (cf. Chesbrough, 2007) . The findings are in line with and support the use of dynamic capabilities theoretical framework in BM research (Teece, 2010; . Our findings strengthen the case for further theorizing and empirical studies of BMI and have implications for strategic and innovation management theory and practice.
The remainder of this paper is structured as follows: The second section contains a brief review on prior large-scale empirical studies on BMI and firm performance. The third section develops two hypotheses, based on dynamic capabilities theorizing, in relation to the effect of BMI on innovation performance. The fourth section describes our data and empirical strategy.
The fifth section outlines our empirical results, while the sixth section discusses contributions and implications of the results. The final section presents our conclusion, limitations and suggestions for further research.
Prior large scale studies on BMI and firm performance
For a general overview of previous research on BMI we refer to recent papers by Foss and Saebi (2017) , Lambert and Davidson, (2013) , Schneider and Spieth (2013) and Spieth, Schneckenberg, and Ricart (2014) . Here we will focus on prior large-scale empirical studies on BMI and performance. In the recent research reviews the BMI research has been described as limited and mainly exploratory employing various definitions of BMs and BMI (Foss and Saebi, 2017; Lambert and Davidson, 2013; Schneider and Spieth, 2013; Spieth, Schneckenberg, and Ricart, 2014) . Research on BMI and firm performance is even more limited and, according to Lambert and Davidson (2013:676) "…in its infancy, so little can be gleaned from the findings"
and rarely extend beyond a single case study of a firm (Schneider and Spieth, 2013; Lambert and Davidson, 2013) or other entities such as alliances (Bouncken and Fredrich, 2016) .
Moreover, BMI research is generally conceptual and descriptive rather than theoretical and explanatory and only few large-scale studies investigates the innovative acts of BMI with firm performance (Foss and Saebi, 2017) . Overall, five larger-scale empirical studies were identified investigating the relation between BMI and various indicators of firm performance (Aspara et al, 2010; Cucculelli and Bettinelli, 2015; Denicolai et al, 2014; Giesen et al, 2007; Kim and Min, 2015) . We briefly review these studies. Aspara et al. (2010) measured the act of managers putting a strategic emphasis on novel BMs or on BM replication and its effects on financial performance. They found that firms that placed a high emphasis on both novel forms of BM, as well as BM replication, outperformed those with no strategic emphasis on BMI. Large firms benefited relatively more from BM replication than small firms, while the opposite was true for novel BMs. Cucculelli and Bettinelli (2015) compare various measures of firm performance (sales growth, profitability, productivity) between BMI-firms and non-BMI-firms in the Italian clothing industry during a ten-year period. BMI is here measured as a change in the firms' BM in the study period. BMIfirms show a significantly higher performance than non-BMI-firms especially if they combine BMI with investment in intangibles. Moreover, BMI-firms that changed to more advanced BMs, such as internationalization, branding or introducing high-quality products showed the highest performance levels. Denicolai, Ramirez and Tidd (2014) define BMI as the combination of internal and external knowledge that create and capture value. The aim of the study is to empirically find the optimal combination of external and internal knowledge generating the highest sales growth. They do find an optimal combination but the level of sales growth differs between different types of companies (high-tech, knowledge-intensive and capital-intensive). Giesen et al (2007) describes a framework for BMI identifying three types of BMI; 1) industry model innovation, i.e., moving into new industries, redefining industries or creating new industries; 2) revenue model innovation study, i.e., reconfiguration of products/services/valuemix and price-models; and 3) enterprise model innovation, i.e., innovating the structure and boundaries of the enterprise. They find no significant differences in financial performance between the three BMI-types and conclude that all three types of BMI may lead to success, but note that the BMI enterprise model is the most used among their 35 case companies. Kim and Lin (2015) compare sales growth of 131 U.S.-based publically traded store-base retailers during a ten-year period whereof 56 retailers added a new business model (e-business) and the rest did not. Just adding a new business model did not significantly increase sales growth, but the retailers that had a strong reputable brand, using that on their e-store, and organized their ebusiness in a separate organizational unit (separated from the physical store organization)
showed a significantly higher sales growth than retailers with a weak brand and operated an integrated organization.
The theorized linkage between BMI and firm performance in these five studies follows three commonly used theorized linkages between strategy and firm performance (Spieth et al, 2016) . A first type of linkage is that superior firm performance is a result of coherent strategy planning and execution (Markides, 2004) . In analogy, a coherent planning and execution of BMI would result in superior performance as advocated in the studies by Aspara et al (2010) and Giesen et al (2007) . A second type of linkage is that BMI, due to its introduction of novelty, will result in temporary monopoly and entrepreneurial rents (Rumelt, 1987) for the noveltyintroducing firm, as indicated in the study of Cucculelli and Bettinelli, 2015 . The resourcebased and dynamic capabilities views of the firm is the foundation of the third type of theorized linkage, due to its social complexity and casual ambiguity (Barney, 1991) , and capabilities to dynamically adapt the BM, replication of the BM by the competitors becomes harder (Teece, 2010; . This may benefit the firm, e.g., by leveraging complementary assets (Kim and Lin, 2015) .
In summary, the few existing large-scale empirical studies indicated that BMI does matter. Managers in firms with explicit emphasis on BMI (Aspara et al, 2010) , engaging in dynamic organizing of complementary (Cucculelli and Bettinelli, 2015; Denicolai et al, 2014) and conflicting assets (Kim and Lin, 2015) are associated with better firm performance than firms without such characteristics. However, all previous large-scale empirical studies employed different methods to conceptualize and measure BMI, as well as different types of performance indicators and used different theories to explain the link between BMI and firm performance (see table 1 ). These differences in conceptualization and measurement of BMI hinder coordinated research efforts among researchers and accumulation of knowledge in the field (Foss and Saebi, 2017) . In order to remedy the situation, we propose that researchers employ large-scale empirical studies where the theorized linkage between BMI and performance is explicit using common strategic and innovation management theories explaining superior performance, such as the dynamic capabilities view, as well as using firm samples with high external validity and refrain from using convenience or best practice samples.
Characteristics of the five prior studies and our study are summarized in 
Theory and hypotheses development -BMI isolating mechanisms
A novel BM is in itself, no matter how much customer value it creates, insufficient to assure the firm competitive advantage (Teece, 2010) . Many BMIs are quite transparent and relatively easy to imitate for the competitors, e.g., moving from ownership of product to leasing of the product, thus the innovating BM firm might not be able to capture the value from innovation. From a strategy perspective, the firm, in order to be successful in its BMI, need to protect their BMI (Teece, 2010) by making them hard to imitate (Barney, 1991) or in a dynamic context continuously "create, adjust, hone, and replace business models" (Teece, 2006 (Teece, :1143 .
Teece (2010) specifies a number of isolating mechanisms, making the BM harder to replicate, when designing business models, based on the dynamic-capability view of the firm (e.g., Teece, 2007) . These are: a) differentiated BM architecture with co-specialized elements, b) complicated process steps, organizational structures, and/or arrangements, c) combinations with (internal or external) complementary assets, d) relationships with external actors, e.g., customers, suppliers, partners, which are unique and/or disturbing to competitors, e) dynamic adaptation of business model elements and architecture, and/or, f) strong intellectual property.
In general, apart from the strong intellectual property, innovating individual elements, such as a product or a distribution process, will be a less effective isolating mechanism than changing the whole architecture (Teece, 2010) . Overall, BMI with high likelihood of gaining competitive advantage will be achieved through organizing of co-specialized assets and complementary assets, introduction and re-configuration of organizational structures, procedures, and external relationships in a dynamic manner (Bock et al, 2012; Teece, 2010) . While many of these organizational changes will be hard to replicate for competitors, due to their social complexity, tacitness, casual ambiguity (Barney, 1991) , and strategic flexibility (Bock et al, 2012) they may also receive protection from the disturbances they create for competitors (Teece, 2010 ).
Overall we argue, based on the dynamic capabilities views of the firm, that product innovations with complementary organizational innovations will not only enable the firm to create value but also to capture value, i.e., to increase firm performance and competitive standing. In the following subsection, we will use the dynamic capabilities framework to develop a hypothesis related to BMI and innovation performance.
Hypotheses development -BMI and innovation performance
For our purposes, in terms of investigating the relationship between BMI and product innovation performance, the product innovation forms the base case. In order to measure and compare product innovation performance the firm need to introduce at least one new product or service during the studied period. From a dynamic capability perspective, an isolated product innovation, without any other changes, should in a relative sense, be easy to detect and replicate for competitors, hence only giving very short-lived competitive advantage if any.
Viewed from a dynamic capability perspective an even better and competitively stronger form would be to combine the product innovation with other forms of innovations, i.e., in internal and boundary-spanning processes, marketing and organizational structures and arrangements including external relations (Teece, 2010) . That would enable the firm to develop even more complex and differentiated co-specialized assets, e.g., in production, distribution and maintenance, and use complementary assets in marketing in the form of co-branding and shared sales channels. Existing research suggests that there are strong complementarities between product and process innovation (Pisano, 1997; Reichstein and Salter, 2006) . Combining product innovations with process innovations firms may offer new and complex services such as directto-user distribution, overnight delivery of spare parts, e-order systems, real-time tracking of products during transports, and/or customized production systems. Process innovations are mostly internally based processes and may also be specifically user innovated by the innovating firm itself (von Hippel, 2005) , thereby being harder to replicate for competitors.
Marketing innovations have generally the aim to maintain, modify or create a customer interface with existing or potential customers, through product design, placement, promotion and/or pricing. Product-related services are easier to replicate than customer-related services (Visnjic et al., 2016) . Novel ways of pricing, such as Freemium-pricing for various software and Internet-services has been a marketing innovation that has attracted considerable attention in the BM literature (e.g., Baden-Fuller and Haefliger, 2013), creating new incentives for the customer, but may in itself be easily replicated by competitors (Teece, 2010) . Marketing innovations combined with organizational innovations may however offer better protection to competitive replication. Examples are better availability of products or services through franchising or licensing (Teece, 2006) , and development of platforms for marketing of related products and services (e.g., Gawer & Henderson, 2007) . A new product's performance may be enhanced by simultaneously introducing significant changes in the organization, i.e., organizational innovations. New types of interaction with other external partners, e.g., partnerships and alliances with suppliers and competitors, may create opportunities for larger exposure for the new product and access to new markets (e.g., Cuccelelli and Bettinelli, 2015; Giesen et al, 2007; Larsson et al, 1998) . The combination and integration of product, process, marketing and organizational innovations can potentially result in a more complex BM with further co-specialization of assets, combinations with several different complementary assets, more complicated processes and structures and increased number of dynamic adaptations, which all will contribute to a hard-to-replicate BM.
The hypothesis states:
Hypothesis: Firms introducing product innovation which is combined with complementary innovations in processes, marketing and the organization, i.e., BMI firms, will exhibit higher product innovation performance than firms only introducing product innovation.
Data and Empirical Strategy 4.1. Data
The data in this study is based on the three waves of the Community Innovation Survey ( In all three waves of the survey, there is information available as to whether a specific firm introduced any new products, services or processes, and the volume of sales that were due to the new product, as well as the amount of inputs (e.g., investments in R&D and in employees' training). In these three waves, there is also information in relation to new marketing and organizational innovation activities. For a description of items surveyed in CIS see Appendix table A1 . The survey consists of a representative sample of firms in industrial and service sectors, with 10 or more employees. In this sample, the stratum with 10−249 employees has a stratified random sampling, with optimal allocations, while the stratum with 250 or more employees covers all firms in Sweden. The response rates in the three waves vary between 63−86 percent, with the later CIS waves having higher response rates, as compared to the earlier ones. Overall, the external validity is excellent.
There were 11,218 observations in total, having combined all three waves of the CIS 2 .
We also merged the CIS-data with other information reflecting the characteristics of the firms (e.g., physical capital, number of employees) based on registered firm-level data maintained by Statistics Sweden (SCB). The descriptive statistics of all variables are presented in Table 2 .
/ 
The dependent variable
Our dependent variable is the product innovation performance of firms. It is the innovative sales of firms, i.e., volume of sales exclusively due to the introduction of product innovation in the same three-year period as it has been introduced divided by the firm's number of employees (log transformed). Product innovation, in turn, is defined by the Oslo Manual (OECD, 2005) as the introduction to the market of new or significantly improved goods or services in terms of their capabilities, user friendliness, components, or sub-systems 3 . Moreover, the identified product innovation performance provides a direct measure of innovation, arguably superior compared to other commonly used indirect measures of innovation, such as patent application or R&D intensity (Kleinknecht, Van Montfort, and Brouwer, 2002; Smith, 2005) . The use of such direct measures to capture a firm's product innovation performance is becoming increasingly used in empirical studies in the fields of management (e.g., Laursen and Salter, 2006; Grimpe and Kaiser, 2010; Klingebiel and Rammer, 2014; Feldman & Tavassoli, 2015; Tavassoli, 2017) as well as in BMI research (Visnjic et al., 2016) . BMI could be expected to generate earnings in the long run, thus product innovation performance is a better indicator than measures of profitability such as return on assets or return on investments (Denicoali et al, 2014) . Moreover, accounting based measures have their limitations due to heterogeneity of industries (Chakravarty, 1986) .
The explanatory variables
Casadesus-Masanell and Zhu (2013: 480) observe that BMI is "a slippery construct to study."
It is not realistic to empirically study all the complexities involved in linking BMI and performance (Foss and Saebi, 2017) 
Control variables
We included a variable that captures the level of innovation inputs by firms, which is measured as the total amount of expenditure in various innovation activities (e.g., R&D investments, employee training, and so on). We also control for the size of firms by including the total number of employees. Moreover, a measure of physical capital per employee is included to control for capital intensity. In order to account for general sector (industry) differences, we used dummies for the NACE 5 single digit categories, which classifies economic sectors into nine broad sectors. We also included year dummies to control for any unobserved time-specific effects, such as business cycles.
Model specifications
We used two different estimators to test our hypotheses and check the robustness of our results.
Firstly, we used a fixed-effect (FE) estimator in order to control for unobserved time-invariant firm-specific heterogeneity, such as managerial characteristics. Omitted variable bias may have occurred, if we had not controlled for unobserved heterogeneity. Moreover, the main advantage of using a FE estimator is that it allows for a correlation between the explanatory variables and the time-invariant firm-specific term, which is a realistic assumption 6 . Secondly, we utilized a random-effect (RE) estimator. The reason for choosing this estimator is because a FE estimator eliminates all time-invariant regressors from the regression analysis. Therefore, by using a FE estimator, neither heterogeneity between industries (sectors) nor heterogeneity between years in the sample can be controlled for. Conversely, when using an RE estimator it does indeed control for such sectoral and temporal heterogeneity. Controlling for sector-heterogeneity is crucial, because it is a stylized fact that firms have a different propensity to innovate in various industrial sectors, due to particular technological regimes that characterize these sectors (Malerba and Orsenigo, 1997) 7 . Moreover, it is important to control for heterogeneity between years, because this can take into account the macroeconomic effects and business cycles that may affect the volume of innovative sales that firms can succeed in achieving.
Endogeneity issues
An important estimation issue relates to the direction of causality in the relationship between BMI and product innovation performance. Our hypotheses implicitly treat the BMI variable as being exogenously determined, which is making a strong assumption. This is because, conceptually, engagement in BMI might also arise from past innovation performance in the form of successful commercialization of innovative products, for example, through the "success breeds success" mechanism. If this is true in our study, the BMI measure would be endogenous and hence it would be difficult to impose a unidirectional relationship, that is, a causal interpretation. In order to (at least partly) deal with this issue, we have further test the robustness of our results by employing an instrumental variable approach and a two-stage least squares (2SLS) estimator. We experimented with various potential instruments that related to some exogenous features of the firm. Firstly, we used sector averages, as a common practice. We also utilized the total number of managers employed within each firm. Both of these variables are conceptually and empirically (correlation) related to BMI, but not necessarily related to sales due to product innovations. Therefore, these variables provide potentially valid instruments.
Based on these potential instruments, we used tests on over-identifying restrictions to examine the validity of the instruments, as well as a Durbin-Wu-Hausman (DWH) test to investigate whether there were in fact any endogeneity issues. The main results suggest that endogeneity problems occurred in only a few cases. In this context, it was important that the main results remained fairly robust. Thus, we will present the 2SLS results only in the Appendix (see Table   A2 ).
Results
The results of our estimation are presented in Table 4 . As described in a previous section, we used two estimators to test the robustness of our results: Models (1) to (4) use FE estimator, while the last model uses a RE estimator. Moreover, first we followed the step-by-step procedure of plug-in main explanatory variables throughout models (1) to (3) and then reported two full models (4) and (5). This would help to rule out possible collinearity issue between main explanatory variables.
TABLE 4 ABOUT HERE/
First of all, our main result shows stable pattern throughout all five models, which roughly speaking, can be an indication of the robustness of our findings. As expected, the introduction of product innovation (PROD) has a positive and significant effect on the volume of innovative sales due to the product innovation, both when it entered the regression alone in Model (2) and in the full models (4) and (5). For comparison, the expected negative effect of non-innovators on innovative sales is shown as model (1). In model (3) and the full models (4, 5), when firms choose to engage in BMI the effect on product innovation performance is significantly higher than choosing product innovation only. This result is again robust both when the variable entered the regression alone in Model (3) and in the full models (4) and (5).
For example, in the full model (4), BMI has 28% (= (453-354)/354) higher impact on product innovation performance than introducing product innovation only 8 . Apart from the magnitude of the effect, the BMI effect is stronger than the PROD effect based on the relevant t-tests. Thus, hypothesis 1 is supported.
8 As all of our models are log-level in this paper, the results are interpreted in the form of semi-elasticity.
Discussion of contributions and implications
Our study shows that BMI does in fact lead to higher product innovation performance as we found significant positive associations between the configuration of BMI and product innovation performance. The BMI firms exhibited the strongest impact on product innovation performance. Apparently, there is substantial economic value in BMI.
Our findings support previous large-scale empirical research (Aspara et al, 2010; Cucculelli and Bettinelli, 2015; Denicolai et al, 2014; Giesen et al, 2007; Kim and Min, 2015) in the sense that they overall point to a positive relationship between BMI and firm performance. In comparison to Aspara et als (2010) who observed performance differences between large and small firms we found no such differences when dividing our sample into small and large firms.
Compared to previous studies our empirical investigation is more systematic in three ways. Firstly, our study provides a clear theoretical rationale why BMI will lead to competitive advantage and thus to higher levels of firm performance. Following Teece's (2010) reasoning that product or service innovations by themselves may create value but not necessarily value capture for the firm, we hypothesized that complementary innovations in several of the business model elements including innovations in processes; marketing and organizational arrangements will act as isolating mechanisms towards replication by competitors. The results of empirical inquiry are in line with this hypothesis and thus support the theoretical framework. Thus, our first and main contribution of this paper is to provide systematic evidence on the relationship between BMI and firm performance than previously reported studies. Secondly, our study also provides a novel method on how to use available CIS data, in order to develop a unique measure of BMI, using the items in CIS and combine it with simultaneous (within the same three-year period) innovation activities in product/service, process, marketing and organization. In terms of accumulation of research knowledge on BMI (Foss and Saebi, 2017) our method provides an opportunity to further investigate performance effects in all EU-countries as well as several other OECD-countries performing similar nationwide surveys. Thirdly, the empirical evidence in this study pinpoints the superior contribution from innovating the BMI compared to only innovating the product and with much broader and representative empirical base than previous studies.
Implications for theory
In accordance with prior research on BMI (Foss and Saebi, 2017) our research suggests the merits of theorizing and analyzing value creation and delivery on the business model level and how this value is captured at the focal firm level. The business model level has generally attracted much less research attention than the firm level or network level (Amit and Zott, 2015) .
In a world where common success factors can explain less of new product success (Evanschitzky et al, 2012) , more industries and firms are experiencing network effects due to increased digitalization, and transactions costs generally are reduced, due to cost reductions in external search, contracting and control, we find it pertinent to increase the research attention to the business model level. Our study has on a general level shown the added product innovation performance by innovating the BM. Our results imply that innovating the BM creates an amplified effect on innovation performance as a measure of a firm's performance, in line with recent findings from Tavassoli and Karlsson (2016) , where such an amplified effect was found using another measure of firm performance, i.e., productivity. To theoretically define the boundaries for the effective use of isolating mechanisms in BMI is an important way forward for further research.
Implications for management
On the subject of how firms do business at the business level model our results indicate that managers should put product innovations in a BMI context, i.e., to make appropriate changes in the organizational architecture of the product and changes to supporting key activities in processes and marketing in order to create and capture more value from the product innovation. Our research does not explicitly specify in which order to innovate; it merely stresses the importance of framing the product innovation in a BMI context in order to create and capture more value (cf. Aspara et al., 2010; Pynnönen, Hallikas and Ritala, 2012) , as well as to implement the innovation activities simultaneously, i.e., in a limited time frame. The business model level indicates the need for a corresponding strategic and innovation management level. Even if the management of BMI can adopt practices and learn from product innovation management there are important differences in terms of more widespread effects on the organization (Bucherer, Eisert, and Gassmann, 2012) and more boundary-spanning activities (Amit and Zott, 2015) . As an example of such BMI management many managers of industrial companies are trying to respond to the threats and opportunities of digitalization, for instance in the automotive industry (KPMG, 2016) . These responses may include the development of various ICT-capabilities in-house as well as in their supplier and dealer networks, to cease collaboration with suppliers and dealers that are not able to upgrade their ICT-capabilities, and connect with more ICT-firms as complementors and partners in order to develop more ICT-based services connected to the car. At the same time, the car manufacturers must safeguard, i.e., to design isolating mechanisms, against competitive attacks from major ICT-firms to take over the car customer relationship possibly dispatching them to metalsmiths (KPMG, 2016) with possible diminishing market power and value capture potential.
Conclusion
There have been few previous studies of large-scale empirical research that have attempted to investigate the link between BMI and performance (Demil et al., 2015; Foss & Saebi, 2017; Lambert and Davidson, 2013; Schneider and Spieth, 2013; Spieth et al, 2016) . Firstly, we provide a theoretical framework, based on the dynamic capabilities view of the firm (Teece, 2006; and specifically Teece's (2010; reasoning that product or service innovations by themselves may create value but not necessarily value capture for the firm. Thus, we hypothesize that complementary innovations in processes, marketing and the organization may act as isolating mechanism towards competitive imitation. The results from the empirical inquiry is in line with the theoretical framework. Secondly, we provide a new method to empirically investigate BMI using CIS data. As this data is regularly collected in the EU member and other OECD countries, our research may be replicated and extended. Our third contribution to the body of knowledge on BMI and firm performance is to provide broad evidence of a significant and positive association between BMI and product innovation performance, based on a representative sample of industry and service firms in Sweden in the period of 2006-2012. BMI firms capture up to 28 % higher product innovation sales than product innovators only. This is a remarkably strong effect. Overall the findings based on this large-scale data study of BMI and innovation performance support the view that BMI is superior to firms only introducing product innovations. Lastly, our results imply the importance of further research attention, theorizing and empirical investigation, to the business model level.
The study clearly has some limitations. Firstly, the CIS is admittedly not designed from the outset to measure BMI. A specific design of survey items of BMI for established firms would be preferable. The CIS does measure product innovations and complementary innovations but it does not measure the alignment (Giesen et al, 2007) of these innovation forms. We have inferred this alignment of innovations by measuring the combination of product innovation with other forms of innovation during the same three-year period (simultaneous introduction). Secondly, our BMI concept assumes that the firm has one BM and that all innovations in the business model elements are reconfigurations of or incremental innovations to the existing BM. However, firms may have more than one BM (Casadesus-Masanell and Tarzijan, 2012) . Consequently, we are not able to determine with certainty that all innovations are linked to the same BM in question. However, most firms in our sample are limited in size,
with an average of 374 employees, which usually implies a limited number of products and
BMs. Thirdly, we have used product innovation performance or innovative sales as our dependent variable which is common practice in innovation research (e.g., Laursen and Salter, 2006; Grimpe and Kaiser, 2010; Klingebiel and Rammer, 2014; Tavassoli, 2015; . In the long run firms need to show more than increasing innovative sales from new products, they need obviously to show profits and return on investments. However, this usually takes longer than three years, which is the period surveyed in each CIS-wave, and requires a more longitudinal research design than available here. Fourth, as our data consist of an unbalanced panel we can only determine an association and not a causal relationship between BMI and product innovation performance. Fifth, information about intellectual property such as patents have not been available to us. Hence, our empirical inquiry has not been able to consider performance effects from this type of isolating mechanism (Teece, 2010) . Future empirical studies, as mentioned above, could apply our BMI measure to other national CIS samples or similar surveys in other parts of the world, in order to replicate and extend our results to other national or industry-specific settings. A final suggestion is to study samples of entrepreneurial firms (Zott and Amit, 2007) , small firms (Aspara et al, 2010) The volume of sales exclusively due to the introduction of production innovation per employee for firm i, in year t (log).
0/1 1 if firm i introduces product innovation into the market in year t, otherwise 0 (NO INNOV). A product innovation is the market introduction of new or significantly improved goods or services, with respect to its capabilities, user friendliness, components, or sub-systems.
0/1 1 if firm i introduces production innovation in year t, AND simultaneously introducing at least one complementary process innovation, AND at least one complementary marketing innovation, AND at least one complementary organizational innovations, otherwise 0.
C
The log amount of the sum of expenditure in the following six innovation activities (per employee) for firm i in year t: internal R&D, external R&D, training of employees, acquisition of machinery, market introduction of innovation, and acquisition of external knowledge. C Total number of employees in firm i, year t (log).
ℎ C Sum of investments in buildings and machines at year end for firm i, in year t (log). Table 2 : The table reports the estimated coefficients, with clustered standard errors over 574 firms in the parentheses. ***, **, and * indicate a significance level of 1%, 5%, and 10% respectively. The dependent variable in all models is product innovation performance, measured as the amount of sales due to innovative products per employee (log). Models (1) to (4) employ the fixed effect (FE) estimator and Model (5) employs the random effect (RE) estimator. The results are based on the unbalanced panel of three waves of the CIS with t=2008, 2010, 2012.
Industry dummies
Appendix- Table A2 : The table reports the estimated coefficients, with clustered standard errors over 5,046 firms in the parentheses for the second stage of a two-stage least square (2SLS) estimation. ***, **, and * indicate a significance level of 1%, 5%, and 10% respectively. The dependent variable in all models is innovation performance, measured as the log amount of sales due to innovative products per employee. In model (6), product innovation (PROD) is instrumented by all explanatory variables, plus its average industry value and the number of managers. In model (7), BMI is instrumented by all the explanatory variables, plus its average industry value and the number of managers. The Sargan test is an over-identification test, with its p-value in parentheses. The null hypothesis is not rejected in any of the models, which means that there is no evidence of over-identification in the specification. The Durbin-Wu-Hausman (DWH) test of endogeneity has its p-value in parentheses. The null hypothesis is strongly rejected in only Model (5), indicating that the endogeneity does not exist in most of the cases. The results are based on the unbalanced panel of three waves of the CIS with t=2008, 2010, 2012.
